Pronova Biopharma ASA

1/31/2013 4:18 AM EST

BASF AS has successfully completed the voluntary 
offer for Pronova BioPharma ASA, Lysaker, Norway, 
[OBX: PRON], which closed today with the payment of 
the offer price to Pronova shareholders. At the same 
time, 295 374 009 tendered shares were transferred to 
BASF AS. BASF AS now holds 295 374 009 shares in 
Pronova BioPharma ASA, equalling 98.19% of the issued 
shares and votes of Pronova BioPharma ASA. 

BASF AS intends to effect a compulsory acquisition 
(squeeze-out) of all issued shares of Pronova 
BioPharma ASA that are not currently owned by BASF AS 
(the "Minority Shares"), in accordance with the 
Norwegian Public Limited Liability Companies Act 
section 4-25 and the Norwegian Securities Trading Act 
section 6-22 as soon as possible.